Jefferies Financial Group assumed coverage on shares of Astera Labs (NASDAQ:ALAB – Free Report) in a research note issued to investors on Monday morning, Marketbeat reports. The brokerage issued a buy rating and a $85.00 target price on the stock.
Several other research analysts also recently commented on ALAB. Roth Mkm began coverage on Astera Labs in a research note on Monday. They set a buy rating and a $85.00 target price for the company. Deutsche Bank Aktiengesellschaft began coverage on Astera Labs in a research note on Monday. They set a buy rating and a $85.00 target price for the company. Needham & Company LLC began coverage on Astera Labs in a research note on Monday. They set a buy rating and a $85.00 target price for the company. Barclays started coverage on Astera Labs in a research note on Monday. They set an overweight rating and a $85.00 target price for the company. Finally, JPMorgan Chase & Co. started coverage on Astera Labs in a research note on Monday. They issued an overweight rating and a $85.00 price objective for the company. Eleven equities research analysts have rated the stock with a buy rating, According to data from MarketBeat, Astera Labs currently has a consensus rating of Buy and an average price target of $86.09.
Astera Labs Trading Down 3.1 %
Insider Buying and Selling at Astera Labs
In other news, Director Jack R. Lazar bought 10,000 shares of the firm’s stock in a transaction on Friday, March 22nd. The stock was acquired at an average price of $36.00 per share, with a total value of $360,000.00. Following the transaction, the director now owns 165,000 shares of the company’s stock, valued at approximately $5,940,000. The acquisition was disclosed in a document filed with the SEC, which is available through this link.
Institutional Trading of Astera Labs
A hedge fund recently bought a new stake in Astera Labs stock. Allspring Global Investments Holdings LLC bought a new stake in shares of Astera Labs, Inc. (NASDAQ:ALAB – Free Report) in the first quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor bought 251,596 shares of the company’s stock, valued at approximately $18,666,000. Allspring Global Investments Holdings LLC owned 0.16% of Astera Labs as of its most recent filing with the Securities and Exchange Commission.
About Astera Labs
Astera Labs, Inc designs, manufactures, and sells semiconductor-based connectivity solutions for cloud and AI infrastructure. Its Intelligent Connectivity Platform is comprised of a portfolio of data, network, and memory connectivity products, which are built on a unifying software-defined architecture that enables customers to deploy and operate high performance cloud and AI infrastructure at scale.
Featured Articles
- Five stocks we like better than Astera Labs
- The 3 Best Fintech Stocks to Buy Now
- Comprehensive PepsiCo Stock Analysis
- The 3 Best Blue-Chip Stocks to Buy Now
- CSX Co.: The Railroad Powering Ahead with an Earnings Beat
- Stock Dividend Cuts Happen Are You Ready?
- 3 Steel Stocks Could Soar on New China Tariffs
Receive News & Ratings for Astera Labs Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Astera Labs and related companies with MarketBeat.com's FREE daily email newsletter.